Category Archives: Clinical Drug Trials

Scientific Misconduct in the Australian Army Malaria Institute’s Clinical Trials of Tafenoquine – Part 1

The New Mefloquine? Mefloquine is now well known to be neurotoxic, one of several synthetic quinolines able to cause acute psychotic reactions and/or a chronic central nervous system (CNS) toxicity syndrome in a significant proportion of people given these drugs … Continue reading

Posted in Clinical Drug Trials, Media, Research | Tagged , , , , , , , , , | 2 Comments

Seroxat Study 329 Opens The Pandora’s Box For All Bogus Anti-Depressant Studies…. — GSK : Licence To (K) ill (Documenting GSK And Seroxat)

http://www.madinamerica.com/2016/05/researchers-deconstruct-ghostwritten-industry-trial-for-antidepressant/ Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant In The News May 14, 2016 Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that … Continue reading

Posted in Clinical Drug Trials | Tagged , , , | 1 Comment

Professor Philip Morris – New Financial Transparency Arrangements Between Doctors and Drug Companies

In early 2015 the Australian Consumer and Competition Commission (ACCC) authorized a new Code of Conduct for Medicines Australia (representing the larger drug companies in Australia but not generic makers). This 18th Code Edition now includes making public all payments … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media | Tagged , , , | Leave a comment

British Parliamentary Inquiry Report on the Use of Lariam™ (Mefloquine) for Military Personnel to be Published on 24 May 2016

The British Parliament’s Defence Select Committee is publishing its report, “An acceptable risk? The use of Lariam for military personnel” on Tuesday 24 May 2016 at 00.01am. Report This is the Committee’s Fourth Report of Session 2015–16 (HC 567) and it can … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Our Stories | Tagged , , , , , , , , , , , , | 1 Comment

Former Health Canada Official: “It’s High Time We Stopped Pretending Mefloquine Was Used Safely”

The federal government should recognize the anti-malaria drug mefloquine was not used safely in a trial during the fateful Somalia mission and address veteran concerns, a former top Health Canada bureaucrat says. The defence and health departments failed to do their … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Uncategorized | Tagged , , , , , , , | Leave a comment

Feature Story (2013) – Army’s Lariam Expert Funded by Drug Maker

A PROFESSOR who has advised the Department of Defence on its practice of prescribing the Lariam anti-malarial drug to Irish troops has previously received research funding from Roche, its manufacturer. Patricia Schlagenhauf, a pharmacist and editor of the Journal of … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Research | Tagged , , , , , , , | Leave a comment

Review of 1998-2014 ADHREC Annual Reports Relating to Trials of Antimalarial Drugs and Vaccines for Tropical Diseases

This is a review paper by Dr Jane Quinn from Charles Sturt University  on the 1998-2014 (inclusive) Australian Defence Human Research Ethics Committee (ADHREC) annual reports relating to trials of antimalarial drugs and vaccines for tropical diseases. The paper provides … Continue reading

Posted in Clinical Drug Trials, Research | Tagged , , , , , , | 2 Comments